Lütfiye Öksüz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lütfiye Öksüz has a total of 245 co-authors. Here are the top co-authors by number of shared publications:
Nezahat Gürler
9 shared publicationsNezahat Gurler
Department of Microbiology and Clinical Microbiology, Istanbul University, Istanbul, Turkey
6 shared publicationsHüseyin Güdücüoğlu
Trakya University Faculty of Medicine
3 shared publicationsMustafa Gül
P Department of Microbiology ; Sutcuimam University Faculty of Medicine ; Kahramanmaras , Turkey
3 shared publicationsN. Gurler
3 shared publicationsNezahat Akpolat
Dicle University Faculty of Medicine
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 2031745
Correction: Differences in microbiota profiles of simple and complicated pediatric appendicitis cases
Wrong content There was a mistake in Figure2-b-c [figure 2
- 11 November 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 2031745
Open AccessCorrection: Differences in microbiota profiles of simple and complicated pediatric appendicitis cases
Wrong content There was a mistake in Figure2-b-c [figure 2
- Open Access
- 4 November 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (11) , 1095
Efflux Pump Inhibitors and Antimicrobial Resistance: A Bibliometric Analysis of Web of Science-Indexed Literature (1991–2025)
Background: Antimicrobial resistance (AMR) is a major global health threat, with bacterial efflux pumps representing an important mechanism that reduces antibiotic efficacy by actively expelling antimicrobial agents from bacterial cells. Efflux pump inhibitors (EPIs) have therefore emerged as promising antibiotic adjuvants. Methods: This study presents a bibliometric analysis of EPI research published between 1991 and 2025 using the Web of Science Core Collection. Of 1078 identified publications, 835 original research articles were included. Publication trends, citation patterns, country and author contributions, scientific disciplines, thematic clusters, and keyword co-occurrence patterns were analyzed using VOSviewer version 1.6.21. Results: Publication output showed an overall upward trend over the study period, with higher annual publication counts in the later years. The United States led in publications (156), citations (9122), and collaborations (80), followed by India (103) and China (94). Lomovskaya et al. (2001) was the most cited article (752 citations). Microbiology was the leading research category (329; 39.4%), followed by Pharmacology & Pharmacy (269; 32.2%). Phytochemicals represented 7.3% of meso-level citation topics. Conclusions: EPI research has expanded over the study period, encompassing a multidisciplinary range of topics primarily related to antimicrobial resistance mechanisms, bacterial efflux systems, and inhibitor discovery. These findings underscore the need to strengthen the connection between fundamental research and translational applications, particularly through the systematic evaluation of EPI efficacy, safety, and therapeutic potential.
- 4 November 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (11) , 1095
Open AccessEfflux Pump Inhibitors and Antimicrobial Resistance: A Bibliometric Analysis of Web of Science-Indexed Literature (1991–2025)
Background: Antimicrobial resistance (AMR) is a major global health threat, with bacterial efflux pumps representing an important mechanism that reduces antibiotic efficacy by actively expelling antimicrobial agents from bacterial cells. Efflux pump inhibitors (EPIs) have therefore emerged as promising antibiotic adjuvants. Methods: This study presents a bibliometric analysis of EPI research published between 1991 and 2025 using the Web of Science Core Collection. Of 1078 identified publications, 835 original research articles were included. Publication trends, citation patterns, country and author contributions, scientific disciplines, thematic clusters, and keyword co-occurrence patterns were analyzed using VOSviewer version 1.6.21. Results: Publication output showed an overall upward trend over the study period, with higher annual publication counts in the later years. The United States led in publications (156), citations (9122), and collaborations (80), followed by India (103) and China (94). Lomovskaya et al. (2001) was the most cited article (752 citations). Microbiology was the leading research category (329; 39.4%), followed by Pharmacology & Pharmacy (269; 32.2%). Phytochemicals represented 7.3% of meso-level citation topics. Conclusions: EPI research has expanded over the study period, encompassing a multidisciplinary range of topics primarily related to antimicrobial resistance mechanisms, bacterial efflux systems, and inhibitor discovery. These findings underscore the need to strengthen the connection between fundamental research and translational applications, particularly through the systematic evaluation of EPI efficacy, safety, and therapeutic potential.
- Open Access
- 5 October 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1966569
Differences in microbiota profiles of simple and complicated pediatric appendicitis cases
This study aimed to identify the differences in microbial composition between simple appendicitis (SA) and complicated appendicitis (CA) in a limited sample size using culture and microbiota analysis. Appendix tissues and rectal swabs for microbiota analysis and conventional cultures were collected from patients. 16S rRNA regions were amplified using a DNA preparation kit with primers designed to target the V3-V4 region. Sixteen (41%) of the patients were classified as CA based on the histopathological analysis, and the rest as SA. The effect size was slightly greater in rectal swab samples than in appendiceal tissue samples. Based on the conventional culture, the most common aerobic bacteria were Escherichia , Klebsiella spp., and Enterococcus spp. A decrease in both Pseudomonadota and Bacteriodota phyla was observed in tissue samples, while a decrease in Bacteriodota and an increase in Pseudomonadota were observed in rectal samples. Differences in the relative abundance of Coprobacter and Hungatella were observed between CAT and SAT samples; however, no genus-level difference remained significant after ANCOM-BC2 multiple-testing correction. The most notable feature of the CAT group was the relatively higher presence of potential pathobionts. Bacteriodes and Roseburia showed higher relative abundance in the SA rectal (SAR) group. The genera Eubacterium and Clostridioides showed a significant increase in both the SAR and CA rectal (CAR) groups. Lower relative abundances of Parvimonas, Prevotella , and Dialister and a higher relative abundance of Tyzzerella were observed in CAR compared with controls, although these differences did not remain significant after multiple-testing correction. In the ANCOM-BC2 pairwise analysis, an unclassified genus within Enterobacteriaceae was significantly enriched in CAR compared with healthy controls (LFC = 3.56, q = 0.003). No statistically significant distinction was shown at the alpha and beta diversity levels between SA and CA cases. Our findings support previous studies on increased density and diversity at the phylum level in the CA group. The main limitations were the limited sample size and the use of pre-operative antibiotics. Microbiota profiling of appendiceal tissue and rectal swab samples may provide complementary information for understanding microbiota-associated patterns in appendicitis; however, the diagnostic or predictive utility of these microbial profiles requires validation in larger, independent cohorts using dedicated predictive modeling and diagnostic performance analyses.
- 5 October 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1966569
Open AccessDifferences in microbiota profiles of simple and complicated pediatric appendicitis cases
This study aimed to identify the differences in microbial composition between simple appendicitis (SA) and complicated appendicitis (CA) in a limited sample size using culture and microbiota analysis. Appendix tissues and rectal swabs for microbiota analysis and conventional cultures were collected from patients. 16S rRNA regions were amplified using a DNA preparation kit with primers designed to target the V3-V4 region. Sixteen (41%) of the patients were classified as CA based on the histopathological analysis, and the rest as SA. The effect size was slightly greater in rectal swab samples than in appendiceal tissue samples. Based on the conventional culture, the most common aerobic bacteria were Escherichia , Klebsiella spp., and Enterococcus spp. A decrease in both Pseudomonadota and Bacteriodota phyla was observed in tissue samples, while a decrease in Bacteriodota and an increase in Pseudomonadota were observed in rectal samples. Differences in the relative abundance of Coprobacter and Hungatella were observed between CAT and SAT samples; however, no genus-level difference remained significant after ANCOM-BC2 multiple-testing correction. The most notable feature of the CAT group was the relatively higher presence of potential pathobionts. Bacteriodes and Roseburia showed higher relative abundance in the SA rectal (SAR) group. The genera Eubacterium and Clostridioides showed a significant increase in both the SAR and CA rectal (CAR) groups. Lower relative abundances of Parvimonas, Prevotella , and Dialister and a higher relative abundance of Tyzzerella were observed in CAR compared with controls, although these differences did not remain significant after multiple-testing correction. In the ANCOM-BC2 pairwise analysis, an unclassified genus within Enterobacteriaceae was significantly enriched in CAR compared with healthy controls (LFC = 3.56, q = 0.003). No statistically significant distinction was shown at the alpha and beta diversity levels between SA and CA cases. Our findings support previous studies on increased density and diversity at the phylum level in the CA group. The main limitations were the limited sample size and the use of pre-operative antibiotics. Microbiota profiling of appendiceal tissue and rectal swab samples may provide complementary information for understanding microbiota-associated patterns in appendicitis; however, the diagnostic or predictive utility of these microbial profiles requires validation in larger, independent cohorts using dedicated predictive modeling and diagnostic performance analyses.
- Open Access
- 27 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7669
Diagnosing Sepsis and Identifying Bacterial Resistance Genes Directly from Whole Blood Using a Rapid Real-Time PCR System
Rapid diagnosis is vital for patients with sepsis. Therefore, this study was conducted to assess the diagnostic performance of rapid Real-Time PCR (rRT-PCR), which detects 32 pathogens and common resistance genes in whole blood within four hours. This study included 160 adult patients with sepsis. Whole-blood samples and BCs were collected from all patients simultaneously, and causative microorganisms were investigated using an rRT-PCR panel and an automated BC system. The panel was also used to detect common resistance genes. The microorganisms most frequently isolated from the BCs were Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli. Among the resistance genes (7.5%) detected by rRT-PCR, mecA, OXA-48, and CTX-M were the most frequently identified. The agreement rate between the BC and rRT-PCR results was statistically significant at 79.4%. In the concordance group, the mean age was higher, while the duration of positive BC signals was significantly shorter. Additionally, the sensitivity and specificity of the rRT-PCR method were found to be 80.7% and 99.0%, respectively. Thus, the panel’s ability to detect the causative bacteria and common resistance genes within four hours offers a significant clinical advantage. This allows for early diagnosis in patients with sepsis, prevents progression to septic shock, and reduces mortality rates.
- 27 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7669
Open AccessDiagnosing Sepsis and Identifying Bacterial Resistance Genes Directly from Whole Blood Using a Rapid Real-Time PCR System
Rapid diagnosis is vital for patients with sepsis. Therefore, this study was conducted to assess the diagnostic performance of rapid Real-Time PCR (rRT-PCR), which detects 32 pathogens and common resistance genes in whole blood within four hours. This study included 160 adult patients with sepsis. Whole-blood samples and BCs were collected from all patients simultaneously, and causative microorganisms were investigated using an rRT-PCR panel and an automated BC system. The panel was also used to detect common resistance genes. The microorganisms most frequently isolated from the BCs were Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli. Among the resistance genes (7.5%) detected by rRT-PCR, mecA, OXA-48, and CTX-M were the most frequently identified. The agreement rate between the BC and rRT-PCR results was statistically significant at 79.4%. In the concordance group, the mean age was higher, while the duration of positive BC signals was significantly shorter. Additionally, the sensitivity and specificity of the rRT-PCR method were found to be 80.7% and 99.0%, respectively. Thus, the panel’s ability to detect the causative bacteria and common resistance genes within four hours offers a significant clinical advantage. This allows for early diagnosis in patients with sepsis, prevents progression to septic shock, and reduces mortality rates.
- Open Access
- 15 June 2026
- Published by MDPI AG in Preprints.org
Microbiota Profiling of Cerebrospinal Fluid in Bacterial Meningitis Using 16S rRNA Metagenomic Sequencing
Bacterial meningitis is a life-threatening central nervous system infection in which rapid and accurate pathogen identification is essential for effective treatment; however, conven-tional culture methods often show limited sensitivity due to prior antibiotic exposure, low microbial load, or fastidious organisms. Background: This study aimed to investigate the cerebrospinal fluid (CSF) microbiota in patients with bacterial meningitis and to evaluate the diagnostic performance of 16S rRNA gene-based metagenomic next-generation se-quencing (mNGS), particularly in culture-negative cases. Methods: CSF samples from 26 patients collected between September 2023 and July 2025 were analyzed. Standard aerobic culture and PCR were performed. DNA was extracted using the ZymoBIOMICS kit and sequenced on the Oxford Nanopore MinION platform using the ONT 16S Barcoding Kit. Sequencing data were processed using Dorado basecalling, FastQC quality control, and taxonomic classification against NCBI and proprietary databases. Results: Conventional culture identified pathogens in 3/26 samples (Klebsiella pneumoniae, Enterobacter aerogenes, Enterococcus spp.), and one sample was PCR-positive for Mycobacterium tuberculosis. In contrast, mNGS detected bacterial pathogens in five samples, confirming all cul-ture-positive organisms and additionally identifying Mycobacterium spp. and Neisseria meningitidis operational taxonomic units in culture-negative cases. Conclusions: 16S rRNA-based mNGS demonstrated higher diagnostic yield than conventional culture and provided complementary value in pathogen detection, particularly in culture-negative meningitis, and may improve clinical diagnostic workflows.
- 15 June 2026
- Published by MDPI AG in Preprints.org
Open AccessMicrobiota Profiling of Cerebrospinal Fluid in Bacterial Meningitis Using 16S rRNA Metagenomic Sequencing
Bacterial meningitis is a life-threatening central nervous system infection in which rapid and accurate pathogen identification is essential for effective treatment; however, conven-tional culture methods often show limited sensitivity due to prior antibiotic exposure, low microbial load, or fastidious organisms. Background: This study aimed to investigate the cerebrospinal fluid (CSF) microbiota in patients with bacterial meningitis and to evaluate the diagnostic performance of 16S rRNA gene-based metagenomic next-generation se-quencing (mNGS), particularly in culture-negative cases. Methods: CSF samples from 26 patients collected between September 2023 and July 2025 were analyzed. Standard aerobic culture and PCR were performed. DNA was extracted using the ZymoBIOMICS kit and sequenced on the Oxford Nanopore MinION platform using the ONT 16S Barcoding Kit. Sequencing data were processed using Dorado basecalling, FastQC quality control, and taxonomic classification against NCBI and proprietary databases. Results: Conventional culture identified pathogens in 3/26 samples (Klebsiella pneumoniae, Enterobacter aerogenes, Enterococcus spp.), and one sample was PCR-positive for Mycobacterium tuberculosis. In contrast, mNGS detected bacterial pathogens in five samples, confirming all cul-ture-positive organisms and additionally identifying Mycobacterium spp. and Neisseria meningitidis operational taxonomic units in culture-negative cases. Conclusions: 16S rRNA-based mNGS demonstrated higher diagnostic yield than conventional culture and provided complementary value in pathogen detection, particularly in culture-negative meningitis, and may improve clinical diagnostic workflows.
- Open Access
- 6 April 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2650946
Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Türkiye, 2019–2025: An update in the 10th to 15th years of routine pneumococcal conjugate vaccination
Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae remains a significant cause of pediatric morbidity. This study updates the serotype distribution and antibiotic resistance of pediatric IPD in Türkiye for 2019-2025, about a decade after 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the National Immunization Program. We conducted a multicenter, hospital-based prospective surveillance between January 2019-April 2025 in children S. pneumoniae isolates from sterile sites (blood, cerebrospinal fluid, pleural fluid) were confirmed by standard methods and serotyped using the Quellung reaction. Antimicrobial susceptibility was determined by gradient test as per CLSI criteria. A total of 203 samples were identified from 203 pediatric cases (median age 4 y, 56.2% boys). The clinical presentations were bacteremia/sepsis (57.6%) and meningitis (26.1%). The leading serotypes were 3 (14.3%), 14 (10.3%), 19F (7.9%), 19A (6.4%), 9N (4.4%), 15A (4.4%). PCV13 serotypes accounted for 46.8% isolates, while PCV7 and PCV10 serotypes were detected in 23.2% and 24.6%, respectively. Broader vaccines would increase coverage: PCV15 (46.8%) and PCV20 (56.7%). Antibiotic susceptibility (non-meningitis breakpoint) remained high for beta-lactams; 91.9% of isolates were penicillin-susceptible, with only 0.7% fully resistant, and cefotaxime resistance was rare (2.7%). Conversely, macrolide resistance was high, with 60.2% of isolates resistant to erythromycin. A decade after PCV13 implementation, vaccine serotypes - particularly 3, 14, 19F, and 19A - still cause nearly half of pediatric IPD, though non-vaccine serotypes such as 9N and 15A are rising. Higher-valent PCVs may improve protection, and continued surveillance is critical to guide vaccine policy and treatment strategies.
- 6 April 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2650946
Open AccessSerotype distribution of Streptococcus pneumoniae in children with invasive diseases in Türkiye, 2019–2025: An update in the 10th to 15th years of routine pneumococcal conjugate vaccination
Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae remains a significant cause of pediatric morbidity. This study updates the serotype distribution and antibiotic resistance of pediatric IPD in Türkiye for 2019-2025, about a decade after 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the National Immunization Program. We conducted a multicenter, hospital-based prospective surveillance between January 2019-April 2025 in children S. pneumoniae isolates from sterile sites (blood, cerebrospinal fluid, pleural fluid) were confirmed by standard methods and serotyped using the Quellung reaction. Antimicrobial susceptibility was determined by gradient test as per CLSI criteria. A total of 203 samples were identified from 203 pediatric cases (median age 4 y, 56.2% boys). The clinical presentations were bacteremia/sepsis (57.6%) and meningitis (26.1%). The leading serotypes were 3 (14.3%), 14 (10.3%), 19F (7.9%), 19A (6.4%), 9N (4.4%), 15A (4.4%). PCV13 serotypes accounted for 46.8% isolates, while PCV7 and PCV10 serotypes were detected in 23.2% and 24.6%, respectively. Broader vaccines would increase coverage: PCV15 (46.8%) and PCV20 (56.7%). Antibiotic susceptibility (non-meningitis breakpoint) remained high for beta-lactams; 91.9% of isolates were penicillin-susceptible, with only 0.7% fully resistant, and cefotaxime resistance was rare (2.7%). Conversely, macrolide resistance was high, with 60.2% of isolates resistant to erythromycin. A decade after PCV13 implementation, vaccine serotypes - particularly 3, 14, 19F, and 19A - still cause nearly half of pediatric IPD, though non-vaccine serotypes such as 9N and 15A are rising. Higher-valent PCVs may improve protection, and continued surveillance is critical to guide vaccine policy and treatment strategies.
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (4) , 473-486
In Vitro Activity of Ceftaroline Alone and in Dual Combinations Against Methicillin-Resistant Staphylococcus aureus Isolates
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (4) , 473-486
In Vitro Activity of Ceftaroline Alone and in Dual Combinations Against Methicillin-Resistant Staphylococcus aureus Isolates
- 30 September 2025
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 88 (4) , 329-337
IN VITRO EFFECTIVENESS OF CEFTOBIPROLE ALONE AND IN COMBINATION AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATED FROM CLINICAL SPECIMENS
- 30 September 2025
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 88 (4) , 329-337
IN VITRO EFFECTIVENESS OF CEFTOBIPROLE ALONE AND IN COMBINATION AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATED FROM CLINICAL SPECIMENS
- 2 April 2025
- Published by Springer Nature in Archives of Microbiology
- Vol. 207 (5) , 1-35
Newly developed antibiotics against multidrug-resistant and carbapenem-resistant Gram-negative bacteria: action and resistance mechanisms
Antimicrobial resistance stands as one of the most urgent global health concerns in the twenty-first century, with projections suggesting that deaths related to drug-resistant infections could escalate to 10 million by 2050 if proactive measures are not implemented. In intensive care settings, managing infections caused by multidrug-resistant (MDR) Gram-negative bacteria is particularly challenging, posing a significant threat to public health and contributing substantially to both morbidity and mortality. There are numerous studies on the antibiotics responsible for resistance in Gram-negative bacteria, but comprehensive research on resistance mechanisms against new antibiotics is rare. Considering the possibility that antibiotics may no longer be effective in combating diseases, it is crucial to comprehend the problem of emerging resistance to newly developed antibiotics and to implement preventive measures to curb the spread of resistance. Mutations in porins and efflux pumps play a crucial role in antibiotic resistance by altering drug permeability and active efflux. Porin modifications reduce the influx of antibiotics, whereas overexpression of efflux pumps, particularly those in the resistance-nodulation-cell division (RND) family, actively expels antibiotics from bacterial cells, significantly lowering intracellular drug concentrations and leading to treatment failure. This review examines the mechanisms of action, resistance profiles, and pharmacokinetic/pharmacodynamic characteristics of newly developed antibiotics designed to combat infections caused by MDR and carbapenem-resistant Gram-negative pathogens. The antibiotics discussed include ceftazidime-avibactam, imipenem-relebactam, ceftolozane-tazobactam, meropenem-vaborbactam, aztreonam-avibactam, delafloxacin, temocillin, plazomicin, cefiderocol, and eravacycline.
- 2 April 2025
- Published by Springer Nature in Archives of Microbiology
- Vol. 207 (5) , 1-35
Newly developed antibiotics against multidrug-resistant and carbapenem-resistant Gram-negative bacteria: action and resistance mechanisms
Antimicrobial resistance stands as one of the most urgent global health concerns in the twenty-first century, with projections suggesting that deaths related to drug-resistant infections could escalate to 10 million by 2050 if proactive measures are not implemented. In intensive care settings, managing infections caused by multidrug-resistant (MDR) Gram-negative bacteria is particularly challenging, posing a significant threat to public health and contributing substantially to both morbidity and mortality. There are numerous studies on the antibiotics responsible for resistance in Gram-negative bacteria, but comprehensive research on resistance mechanisms against new antibiotics is rare. Considering the possibility that antibiotics may no longer be effective in combating diseases, it is crucial to comprehend the problem of emerging resistance to newly developed antibiotics and to implement preventive measures to curb the spread of resistance. Mutations in porins and efflux pumps play a crucial role in antibiotic resistance by altering drug permeability and active efflux. Porin modifications reduce the influx of antibiotics, whereas overexpression of efflux pumps, particularly those in the resistance-nodulation-cell division (RND) family, actively expels antibiotics from bacterial cells, significantly lowering intracellular drug concentrations and leading to treatment failure. This review examines the mechanisms of action, resistance profiles, and pharmacokinetic/pharmacodynamic characteristics of newly developed antibiotics designed to combat infections caused by MDR and carbapenem-resistant Gram-negative pathogens. The antibiotics discussed include ceftazidime-avibactam, imipenem-relebactam, ceftolozane-tazobactam, meropenem-vaborbactam, aztreonam-avibactam, delafloxacin, temocillin, plazomicin, cefiderocol, and eravacycline.
- 20 September 2024
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (10) , 1-18
Effect of Staphylococcus aureus colonization and immune defects on the pathogenesis of atopic dermatitis
Atopic dermatitis (AD) is a common and recurrent skin disease characterized by skin barrier dysfunction, inflammation and chronic pruritus, with wide heterogeneity in terms of age of onset, clinical course and persistence over the lifespan. Although the pathogenesis of the disease are unclear, epidermal barrier dysfunction, immune and microbial dysregulation, and environmental factors are known to be critical etiologies in AD pathology. The skin microbiota represents an ecosystem consisting of numerous microbial species that interact with each other as well as host epithelial cells and immune cells. Although the skin microbiota benefits the host by supporting the basic functions of the skin and preventing the colonization of pathogens, disruption of the microbial balance (dysbiosis) can cause skin diseases such as AD. Although AD is a dermatological disease, recent evidence has shown that changes in microbiota composition in the skin and intestine contribute to the pathogenesis of AD. Environmental factors that contribute to skin barrier dysfunction and microbial dysbiosis in AD include allergens, diet, irritants, air pollution, epigenetics and microbial exposure. Knowing the microbial combination of intestin, as well as the genetic and epigenetic determinants associated with the development of autoantibodies, may help elucidate the pathophysiology of the disease. The skin of patients with AD is characterized by microbial dysbiosis as a result of reduced microbial diversity and overgrowth of the pathogens such as Staphylococcus aureus. Recent studies have revealed the importance of building a strong immune response against microorganisms during childhood and new mechanisms of microbial community dynamics in modulating the skin microbiome. Numerous microorganisms are reported to modulate host response through communication with keratinocytes, specific immune cells and adipocytes to improve skin health and barrier function. This growing insight into bioactive substances in the skin microbiota has led to novel biotherapeutic approaches targeting the skin surface for the treatment of AD. This review will provide an updated overview of the skin microbiota in AD and its complex interaction with immune response mechanisms, as well as explore possible underlying mechanisms in the pathogenesis of AD and provide insights into new therapeutic developments for the treatment of AD. It also focuses on restoring skin microbial homeostasis, aiming to reduce inflammation by repairing the skin barrier.
- 20 September 2024
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (10) , 1-18
Effect of Staphylococcus aureus colonization and immune defects on the pathogenesis of atopic dermatitis
Atopic dermatitis (AD) is a common and recurrent skin disease characterized by skin barrier dysfunction, inflammation and chronic pruritus, with wide heterogeneity in terms of age of onset, clinical course and persistence over the lifespan. Although the pathogenesis of the disease are unclear, epidermal barrier dysfunction, immune and microbial dysregulation, and environmental factors are known to be critical etiologies in AD pathology. The skin microbiota represents an ecosystem consisting of numerous microbial species that interact with each other as well as host epithelial cells and immune cells. Although the skin microbiota benefits the host by supporting the basic functions of the skin and preventing the colonization of pathogens, disruption of the microbial balance (dysbiosis) can cause skin diseases such as AD. Although AD is a dermatological disease, recent evidence has shown that changes in microbiota composition in the skin and intestine contribute to the pathogenesis of AD. Environmental factors that contribute to skin barrier dysfunction and microbial dysbiosis in AD include allergens, diet, irritants, air pollution, epigenetics and microbial exposure. Knowing the microbial combination of intestin, as well as the genetic and epigenetic determinants associated with the development of autoantibodies, may help elucidate the pathophysiology of the disease. The skin of patients with AD is characterized by microbial dysbiosis as a result of reduced microbial diversity and overgrowth of the pathogens such as Staphylococcus aureus. Recent studies have revealed the importance of building a strong immune response against microorganisms during childhood and new mechanisms of microbial community dynamics in modulating the skin microbiome. Numerous microorganisms are reported to modulate host response through communication with keratinocytes, specific immune cells and adipocytes to improve skin health and barrier function. This growing insight into bioactive substances in the skin microbiota has led to novel biotherapeutic approaches targeting the skin surface for the treatment of AD. This review will provide an updated overview of the skin microbiota in AD and its complex interaction with immune response mechanisms, as well as explore possible underlying mechanisms in the pathogenesis of AD and provide insights into new therapeutic developments for the treatment of AD. It also focuses on restoring skin microbial homeostasis, aiming to reduce inflammation by repairing the skin barrier.